| Dr Hatim S Al-jaroushi, MD | |
|
3100 Maccorkle Ave Se Ste 205, Charleston, WV 25304-1228 | |
| (304) 720-7305 | |
| (304) 720-7310 |
| Full Name | Dr Hatim S Al-jaroushi |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 23 Years |
| Location | 3100 Maccorkle Ave Se Ste 205, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477874295 | NPI | - | NPPES |
| WV6289A | Other | WV | MEDICARE PTAN |
| 1477874295 | Medicaid | WV |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Virginia University Hospitals | Morgantown, WV | Hospital |
| United Hospital Center | Bridgeport, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, announced today the initiation of its first clinical trial to evaluate the Safety and Efficacy of PAZ320 when added to oral agents or Insulin regimen in Patients with Type 2 Diabetes Mellitus.
From algae to zebrafish, life under the microscope can be beautiful, surprising and mysterious. This week, amazing glimpses of the unseen universe earned top prizes in the 2014 Olympus BioScapes Digital Imaging Competition®, the world's foremost forum for showcasing microscope images of life science subjects.
Union Dental Holdings, Inc. - http://www.uniondental.com - a provider of multi-state dental services for union members, is pleased to announce that it has built a specially designed operatory to perform Oral Surgery and IV Sedation Dentistry. This opens a completely new element of dentistry because there are a tremendous amount of patients who require the sedation in order to perform these procedures.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
› Verified 7 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, announced today the initiation of its first clinical trial to evaluate the Safety and Efficacy of PAZ320 when added to oral agents or Insulin regimen in Patients with Type 2 Diabetes Mellitus.
From algae to zebrafish, life under the microscope can be beautiful, surprising and mysterious. This week, amazing glimpses of the unseen universe earned top prizes in the 2014 Olympus BioScapes Digital Imaging Competition®, the world's foremost forum for showcasing microscope images of life science subjects.
Union Dental Holdings, Inc. - http://www.uniondental.com - a provider of multi-state dental services for union members, is pleased to announce that it has built a specially designed operatory to perform Oral Surgery and IV Sedation Dentistry. This opens a completely new element of dentistry because there are a tremendous amount of patients who require the sedation in order to perform these procedures.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
› Verified 7 days ago
| Entity Name | Charleston Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124248752 PECOS PAC ID: 3375441637 Enrollment ID: O20031223000426 |
News Archive
Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, announced today the initiation of its first clinical trial to evaluate the Safety and Efficacy of PAZ320 when added to oral agents or Insulin regimen in Patients with Type 2 Diabetes Mellitus.
From algae to zebrafish, life under the microscope can be beautiful, surprising and mysterious. This week, amazing glimpses of the unseen universe earned top prizes in the 2014 Olympus BioScapes Digital Imaging Competition®, the world's foremost forum for showcasing microscope images of life science subjects.
Union Dental Holdings, Inc. - http://www.uniondental.com - a provider of multi-state dental services for union members, is pleased to announce that it has built a specially designed operatory to perform Oral Surgery and IV Sedation Dentistry. This opens a completely new element of dentistry because there are a tremendous amount of patients who require the sedation in order to perform these procedures.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hatim S Al-jaroushi, MD 3100 Maccorkle Ave Se Ste 205, Charleston, WV 25304-1228 Ph: (304) 720-7305 | Dr Hatim S Al-jaroushi, MD 3100 Maccorkle Ave Se Ste 205, Charleston, WV 25304-1228 Ph: (304) 720-7305 |
News Archive
Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, announced today the initiation of its first clinical trial to evaluate the Safety and Efficacy of PAZ320 when added to oral agents or Insulin regimen in Patients with Type 2 Diabetes Mellitus.
From algae to zebrafish, life under the microscope can be beautiful, surprising and mysterious. This week, amazing glimpses of the unseen universe earned top prizes in the 2014 Olympus BioScapes Digital Imaging Competition®, the world's foremost forum for showcasing microscope images of life science subjects.
Union Dental Holdings, Inc. - http://www.uniondental.com - a provider of multi-state dental services for union members, is pleased to announce that it has built a specially designed operatory to perform Oral Surgery and IV Sedation Dentistry. This opens a completely new element of dentistry because there are a tremendous amount of patients who require the sedation in order to perform these procedures.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
› Verified 7 days ago
Dr. Asif Rahman, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2345 Chesterfield Ave, Suite 301, Charleston, WV 25304 Phone: 304-344-2900 Fax: 304-344-9385 | |
David L Namay, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3411 B Noyes Avenue Se, Charleston, WV 25304 Phone: 304-720-3206 Fax: 304-720-3207 | |
Joseph Jarrell, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 333 Laidley St Ste 605, Charleston, WV 25301 Phone: 304-720-7235 Fax: 304-720-7236 | |
Samar Ryiad Sankari, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1097 Fledderjohn Rd, Charleston, WV 25314 Phone: 304-720-1963 Fax: 304-720-1966 | |
Brittain Mcjunkin, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3110 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-347-1300 | |
Rupali N. Sangrampurkar, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-388-5848 Fax: 304-388-9654 | |
George Zaldivar, M.D Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Maccorkle Avenue Se, Suite 404, Charleston, WV 25304 Phone: 304-346-1811 Fax: 304-343-3086 |